$EIKN
Eikon Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$7.95
▲+6.00%+$0.450
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateEikon Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is EIKN up today? It is at $7.95 (+6.00%), and our scanner flagged it 74 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment EIKN spikes, and full due diligence on EIKN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $EIKN 74 times in the last 30 days. Create a free account to track $EIKN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on EIKN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for EIKN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystQ3 Company Update August 2026, from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Column Group Iv Gp, Lp Beneficial Owner (10%) | Bought (open market) | +89K 0.2% of company | added 1.5% | 5.87M | $1.0M at $11.56 | Sep 3, 26 |
Lux Venture Partners V, Llc Beneficial Owner (10%) | Acquired (grant/award) | +5.70M 10.5% of company | added 100% | 5.97M | n/a | Feb 6, 26 |
Wolfe Josh Director | Acquired (grant/award) | +5.70M 10.5% of company | added 100% | 5.97M | n/a | Feb 6, 26 |
Column Group Iv Gp, Lp Beneficial Owner (10%) | Acquired (grant/award) | +3.60M 6.6% of company | n/a | 2.87M | n/a | Feb 6, 26 |
Column Group Iv Gp, Lp Beneficial Owner (10%) | Bought (open market) | +2.12M 3.9% of company | added 58% | 5.78M | $38.1M at $18.00 | Feb 6, 26 |
Perlmutter Roger M Officer | Acquired (grant/award) | +285K 0.5% of company | n/a | 285K | n/a | Feb 6, 26 |
Lux Venture Partners V, Llc Beneficial Owner (10%) | Bought (open market) | +278K 0.5% of company | n/a | 139K | $5.0M at $18.00 | Feb 4, 26 |
Wolfe Josh Director | Bought (open market) | +278K 0.5% of company | n/a | 139K | $5.0M at $18.00 | Feb 4, 26 |
Frazier Kenneth C Director | Bought (open market) | +111K 0.2% of company | n/a | 111K | $2.0M at $18.00 | Feb 4, 26 |
Foresite Capital Management Iv, Llc Beneficial Owner (10%) | Acquired (grant/award) | +4.04M 7.5% of company | n/a | 1.94M | n/a | Feb 4, 26 |
Foresite Capital Management Iv, Llc Beneficial Owner (10%) | Bought (open market) | +56K 0.1% of company | added 1.4% | 4.10M | $1000K at $18.00 | Feb 4, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on EIKN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for EIKN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
EIKN last traded at $7.95, up 6.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Eikon Therapeutics, Inc. Common Stock (EIKN) is next expected to report earnings on Thursday, November 12, 2026, about 34 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The EIKN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged EIKN 74 times in the last 30 days.
EIKN (Eikon Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $406M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge EIKN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$EIKN discussion
Sign in to ask a question or join the discussion.